Table 2 Centrosome aberrations and stemline scatter index (SSI)

From: Characterisation of breast fine-needle aspiration biopsies by centrosome aberrations and genomic instability

  

Percentage of cells with centrosome aberrations

SSI (%)

 

n

Mean

(95% confidence interval)

Median

s.d.

Mean

(95% confidence interval)

Median

s.d.

All

58

4.14

(3.00–5.29)

2.10

4.35

12.68

(9.02–16.33)

6.50

13.90

(a) Benign lesions

18

0

 

0

0

4.88

(4.23–5.53)

4.70

1.31

(b) D a gs b +A c gs

19

2.06

(1.93–2.18)

2.00

0.26

5.90

(5.25–6.55)

6.20

1.37

 Dgs

12

2.12

(1.95–2.28)

2.10

0.26

5.65

(4.91–6.39)

6.15

1.17

 Ags

7

1.96

(1.71–2.20)

1.90

0.26

6.33

(4.82–7.84)

7.40

1.64

(c) Agu d invasive+Agu DCIS e

21

9.58

(8.75–10.41)

9.30

1.82

25.49

(17.93–33.06)

19.40

16.62

 Agu invasive

14

10.26

(9.30–11.22)

10.25

1.66

28.59

(17.72–39.46)

20.45

18.83

 Agu DCIS

7

8.21

(6.97–9.46)

8.10

1.35

19.30

(10.74–27.86)

17.80

9.25

  1. aType I carcinomas with a diploid (D) stemline.
  2. bGenomically stable (gs) tumours.
  3. cType IV carcinomas with an aneuploid (A) stemline.
  4. dGenomically unstable (gu) tumours.
  5. eDuctal Carcinoma In Situ (DCIS).